摘要: Despite the alarming increase in prevalence of drug-resistant bacterial infections, far fewer new antibiotics have been approved past decade than at peak 1980s ( 1 ). The situation is particularly for serious infections by Gram-negative bacteria, some which are becoming untreatable modern 2 – 4 Particularly low- and middle-income countries, an everyday reality hospital care settings 5 Increasing recognition this problem spurring a number public private initiatives on both sides Atlantic 6 8 To more effectively counter threat emerging resistance, we must innovative development harness advances diagnostic technology to preserve their efficacy.